A detailed history of Citigroup Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 16,509 shares of THRD stock, worth $170,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,509
Previous 5,464 202.14%
Holding current value
$170,372
Previous $71,000 214.08%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.86 - $15.0 $119,948 - $165,675
11,045 Added 202.14%
16,509 $223,000
Q2 2024

Aug 12, 2024

BUY
$8.74 - $15.54 $13,284 - $23,620
1,520 Added 38.54%
5,464 $71,000
Q1 2024

May 10, 2024

BUY
$8.6 - $11.24 $3,156 - $4,125
367 Added 10.26%
3,944 $37,000
Q4 2023

Feb 09, 2024

BUY
$5.97 - $11.47 $21,300 - $40,924
3,568 Added 39644.44%
3,577 $39,000
Q3 2023

Nov 09, 2023

SELL
$4.92 - $7.09 $28,496 - $41,065
-5,792 Reduced 99.84%
9 $0
Q2 2023

Aug 10, 2023

BUY
$4.18 - $5.33 $24,248 - $30,919
5,801 New
5,801 $27,000
Q4 2022

Feb 09, 2023

BUY
$4.0 - $23.97 $1,656 - $9,923
414 New
414 $1,000

Others Institutions Holding THRD

About Third Harmonic Bio, Inc.


  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $416M
More about THRD
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.